The Lab Protocol is a series focused on the science, operations and regulation challenges clinical laboratories face. Each post addresses a discrete topic, highlighting what is changing, what is being enforced and where laboratories often misread risk until it surfaces in a survey, audit or transaction.

Molecular Testing Expansion in Pathology: Where Strategy, Validation and Oversight Intersect – July 7, 2026